Clinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes Mellitus

Clinical trial NCT07258394 · RECRUITING

Trial details

NCT number: NCT07258394
Sponsor: Nanjing Medical University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Type 1 Diabetes

Start date: 2026-01-27
Primary completion: 2028-12-31
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.